Last reviewed · How we verify
Malignant tumor of lung
Approved treatments
- Laserphyrin · Meiji Seika Pharm
- Valchlor · Recordati
Valchlor works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Vindesin · The Lymphoma Academic Research Organisation
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Doridamina
Doridamina works by inhibiting the mitochondrial pyruvate carrier 2, which is involved in the production of energy within cells. - Eldisine
- Liposomal Doxorubicin · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Trexall · Generic (originally Lederle Laboratories)
Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune). - Methotrexat · Biocad
- Hydroxydaunomycin · Weill Medical College of Cornell University
- Adriamycin · Johann Wolfgang Goethe University Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of lung patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of lung treatment landscape brief
- Malignant tumor of lung treatment updates RSS
Frequently asked questions about Malignant tumor of lung
What drugs treat Malignant tumor of lung?
Tracked treatments include Laserphyrin, Valchlor, Vindesin, adriacin, Hydroxydaunorubicin, Doridamina, Eldisine, Liposomal Doxorubicin.
What is the treatment for Malignant tumor of lung?
Standard treatment for Malignant tumor of lung includes Laserphyrin, Valchlor, Vindesin, adriacin, Hydroxydaunorubicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of lung patent cliff · Malignant tumor of lung CI report
- Treatment: Laserphyrin · Meiji Seika Pharm
- Treatment: Valchlor · Recordati
- Treatment: Vindesin · The Lymphoma Academic Research Organisation
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing